Correction of transaction information for
derivatives trading in February 2022
Date of events
2022/03/14
To which item it meets
paragraph 53
Statement
1.Date of occurrence of the event:2022/03/14
2.Company name:TCI CO.,Ltd
3.Relationship to the Company (please enter "head
office" or "subsidiaries"): Head office
4.Reciprocal shareholding ratios: NA
5.Cause of occurrence:Correction of the matched unit
6.Information items/ statements to be corrected: transaction information for
derivatives trading in February 2022.
7.Amounts/ contents/ number of page to be corrected:
Forward contract (unit: NT 1,000)
Contract total amount not reversed: 1,314,904,598
Fair values of not reversed contracts: -11,029,474
The amount of unrealized profits or losses recognized for the not reversed
contracts in this year: -11,029,474
8.Amounts/ contents/ number of page after correction:
Forward contract (unit: NT 1,000)
Contract total amount not reversed: 1,314,904
Fair values of not reversed contracts: -11,029
The amount of unrealized profits or losses recognized for the not reversed
contracts in this year: -11,029
9.Countermeasures: Correct and re-upload the information
to the Market Observation Post System (MOPS).
10.Any other matters that need to be specified: NA.
Attachments
Original Link
Original Document
Permalink
Disclaimer
TCI Co. Ltd. published this content on 14 March 2022 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 14 March 2022 15:43:10 UTC.
TCI Co Ltd is a Taiwan-based company principally engaged in the research, development, manufacture and sale of functional beverages, health foods and beauty care products. The health food includes various types of food, such as hard capsules, soft capsules, pastilles, powder, liquid packs, jelly and oil-based hard gelatine. The beauty care products include facial and body care products, such as facial masks, eye masks, facial cleansers, anti-acne gel, whitening cream, slimming cream, breast enhancement cream and serum. In addition, the Company is engaged in the production and sale of biological products, various medical devices and confidential chemical materials. The Company distributes its products in domestic market and to overseas markets.